This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various bioactive molecules. Its structure is particularly valuable in the creation of compounds targeting neurological and psychiatric disorders, such as antidepressants and anxiolytics. Additionally, it plays a role in the development of drugs with potential anti-inflammatory and analgesic properties. Its methoxyacetyl group and piperazinone core make it a versatile building block for designing molecules with enhanced pharmacokinetic profiles. Researchers also explore its use in the synthesis of novel compounds for treating metabolic and cardiovascular diseases.